These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 12461740

  • 1. Serum procalcitonin concentrations in bacterial pneumonia in children: a negative result in primary healthcare settings.
    Korppi M, Remes S, Heiskanen-Kosma T.
    Pediatr Pulmonol; 2003 Jan; 35(1):56-61. PubMed ID: 12461740
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children.
    Korppi M, Don M, Valent F, Canciani M.
    Acta Paediatr; 2008 Jul; 97(7):943-7. PubMed ID: 18422803
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children.
    Galetto-Lacour A, Alcoba G, Posfay-Barbe KM, Cevey-Macherel M, Gehri M, Ochs MM, Brookes RH, Siegrist CA, Gervaix A.
    Pediatr Infect Dis J; 2013 Nov; 32(11):1175-9. PubMed ID: 23694836
    [Abstract] [Full Text] [Related]

  • 9. Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children.
    Agnello L, Bellia C, Di Gangi M, Lo Sasso B, Calvaruso L, Bivona G, Scazzone C, Dones P, Ciaccio M.
    Clin Biochem; 2016 Jan; 49(1-2):47-50. PubMed ID: 26386341
    [Abstract] [Full Text] [Related]

  • 10. Non-specific host response markers in the differentiation between pneumococcal and viral pneumonia: what is the most accurate combination?
    Korppi M.
    Pediatr Int; 2004 Oct; 46(5):545-50. PubMed ID: 15491381
    [Abstract] [Full Text] [Related]

  • 11. Serum procalcitonin in pneumococcal pneumonia in children.
    Korppi M, Remes S.
    Eur Respir J; 2001 Apr; 17(4):623-7. PubMed ID: 11401055
    [Abstract] [Full Text] [Related]

  • 12. A three-step diagnosis of pediatric pneumonia at the emergency department using clinical predictors, C-reactive protein, and pneumococcal PCR.
    Alcoba G, Keitel K, Maspoli V, Lacroix L, Manzano S, Gehri M, Tabin R, Gervaix A, Galetto-Lacour A.
    Eur J Pediatr; 2017 Jun; 176(6):815-824. PubMed ID: 28474099
    [Abstract] [Full Text] [Related]

  • 13. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index.
    Masiá M, Gutiérrez F, Shum C, Padilla S, Navarro JC, Flores E, Hernández I.
    Chest; 2005 Oct; 128(4):2223-9. PubMed ID: 16236878
    [Abstract] [Full Text] [Related]

  • 14. Differentiation of bacterial and viral community-acquired pneumonia in children.
    Don M, Valent F, Korppi M, Canciani M.
    Pediatr Int; 2009 Feb; 51(1):91-6. PubMed ID: 19371285
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic and prognostic value of procalcitonin in community-acquired pneumonia.
    Horie M, Ugajin M, Suzuki M, Noguchi S, Tanaka W, Yoshihara H, Kawakami M, Kichikawa Y, Sakamoto Y.
    Am J Med Sci; 2012 Jan; 343(1):30-5. PubMed ID: 22207498
    [Abstract] [Full Text] [Related]

  • 16. Serial quantification of procalcitonin (PCT) predicts clinical outcome and prognosis in patients with community-acquired pneumonia (CAP).
    Tamura M, Watanabe M, Nakajima A, Kurai D, Ishii H, Takata S, Nakamoto K, Sohara E, Honda K, Nakamura M, Inui T, Wada H, Takizawa H, Goto H.
    J Infect Chemother; 2014 Feb; 20(2):97-103. PubMed ID: 24462441
    [Abstract] [Full Text] [Related]

  • 17. Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia. Mowgli Study Group.
    Esposito S, Blasi F, Bellini F, Allegra L, Principi N, Mowgli Study Group.
    Eur Respir J; 2001 Feb; 17(2):241-5. PubMed ID: 11334126
    [Abstract] [Full Text] [Related]

  • 18. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia.
    Kang YA, Kwon SY, Yoon HI, Lee JH, Lee CT.
    Korean J Intern Med; 2009 Dec; 24(4):337-42. PubMed ID: 19949732
    [Abstract] [Full Text] [Related]

  • 19. Procalcitonin levels in community-acquired pneumonia - correlation with aetiology and severity.
    Johansson N, Kalin M, Backman-Johansson C, Larsson A, Nilsson K, Hedlund J.
    Scand J Infect Dis; 2014 Nov; 46(11):787-91. PubMed ID: 25195651
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of serum procalcitonin levels in pulmonary tuberculosis.
    Ugajin M, Miwa S, Shirai M, Ohba H, Eifuku T, Nakamura H, Suda T, Hayakawa H, Chida K.
    Eur Respir J; 2011 Feb; 37(2):371-5. PubMed ID: 20530033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.